Hai Nguyen

상무 (Associate Principal)


Data & Analytics, Market Research

Hai Nguyen is an Associate Principal at EVERSANA MANAGEMENT CONSULTING with a background spanning life sciences, healthcare administration, and financial/economic consulting. Hai has vast experiences in conducting quantitative and qualitative primary market research, building complex models, and translating data analytics and business insights into actionable recommendations for clients.

At EVERSANA, she has served on a variety of projects across various therapeutic areas to support market opportunity assessment, market segmentation, pricing and market access, and other core commercial strategies for pharmaceutical and medical device clients. Hai holds a Master’s in Health Administration from Columbia University and a Bachelor’s degree in Economics from Reed College. She has special interests in topics related to health equity issues and business strategies to support access to healthcare for broader patient populations.

Articles by Hai Nguyen

Account Engagement Excellence: How Advanced Analytics Can Enable Next-Generation Account Segmentation

Account/customer segmentation is a crucial exercise at the beginning of any strategy related to healthcare provider, patient, or payer engagement. Due to the large variety of customers, it is critical to know one’s customers well, from basic information such as demographics, firmographics, and geography, to more nuanced aspects of the customers’ beliefs, attitudes, and the […]

Social Determinants of Health – What Pharma Can Do!

The US Department of Health and Human Services defines Social Determinants of Health (SDoH) as conditions in the places where people live, learn, work, and play that affect a wide range of health risks and outcomes.1 They can be grouped into five major categories: economic stability, education access and quality, healthcare access and quality, neighborhood […]

Rx-to-OTC Switch Tips: Identifying the Right Timing, Conditions, and Approach for Rx-to-OTC Conversion

Exploring the idea of converting a prescription (Rx) drug to an over-the-counter (OTC) product can be a useful part of life cycle management and loss of exclusivity planning. However, while an Rx-to-OTC switch could provide significant benefits to patients and a potential revenue source for drugs facing loss of exclusivity (LOE), manufacturers considering this strategy […]

Interested in scheduling a meeting or speaking event?


  • This field is for validation purposes and should be left unchanged.